ILD & Early Rheumatoid Arthritis

Trial Objective

The purpose of this study is to learn how interstitial lung disease (ILD) develops and progresses over time in people with early rheumatoid arthritis (RA). There is evidence that RA starts in the lungs in a subset of patients and through this study researchers will be looking at the relationship between your RA and your lungs.

ILD and Early Rheumatoid Arthritis


This trial is active and currently recruiting.

How to Participate

For more information, contact Faduma Ahmed at 303.398.1285 or complete the form below.

Who Can Participate

Adults diagnosed with rheumatoid arthritis within the last two years may be eligible to participate.

Estimated Time Commitment

5 in-person visits over 18 months

Trial Location

National Jewish Main Campus, Denver, CO


Not Provided

Trial Sponsors

Boehringer Ingelheim




Any Gender


Request More Information